The Pharma Data

MARCH 23, 2022

To treat Ebola virus infections, researchers are taking a close look at a key piece of the virus: polymerase. Polymerase is a viral protein that directs how Ebola virus replicates its genome as it infects new hosts. Drugs that target polymerase could potentially treat Ebola virus infections and save lives.

Virus 52

Virus Small Molecule Protein Production Research 52

PLOS: DNA Science

JUNE 13, 2024

The virus SARS-CoV-2 emerged in Wuhan, home of a premiere research institute that focuses on viruses. An altered virus could have escaped. Evidence that the virus emerged, or escaped, from the wildlife trade is lacking. Her points: 1. Coincidence? I’ve never thought so. RaTG13 shares about 96.1%

Virus 52

Virus RNA DNA Science 52

The Pharma Data

JANUARY 13, 2021

Germany-based Cevec Pharmaceuticals GmbH signed a licensing agreement with Biogen for the use of its proprietary ELEVECTA Technology for the manufacturing of adeno-associated virus (AAV) vectors for gene therapy applications. The deal will provide Biogen the rights to use the technology across their portfolio of gene therapy products.

Licensing 52

Licensing Licensing Clinical Trials Vaccine 52

Codon

MAY 30, 2023

This paper presents a modular approach to convert CO2 into olefins and other molecules by assigning different tasks to distinct microbes. Biosynthesis of cannabigerol and cannabigerolic acid, the gateways to further cannabinoid production. Read *An engineered influenza virus to deliver antigens for lung cancer vaccination.

DNA 52

DNA RNA Engineering Vaccine 52

Codon

MAY 30, 2023

This paper presents a modular approach to convert CO2 into olefins and other molecules by assigning different tasks to distinct microbes. Biosynthesis of cannabigerol and cannabigerolic acid, the gateways to further cannabinoid production. Read *An engineered influenza virus to deliver antigens for lung cancer vaccination.

DNA 52

DNA RNA Engineering Vaccine 52